Objective: To determine which serotoninergic receptor subtype(s) media
tes the regional vasodilator response to scald injury. Design: Prospec
tive, randomized trial. Setting: Microcirculation research laboratory.
Subjects: Anesthetized dogs. Interventions: Mechanically ventilated d
ogs underwent cannulation of a brachial artery and placement of an ult
rasonic flow probe around one femoral artery, Ah animals received a 2%
to 3% body surface area partial thickness scald injury by immersing t
he paw ipsilateral to the instrumented femoral artery into 100 degrees
C water for 5 secs. In one group of dogs, BMY 7378 (a serotoninergic(
1A) receptor antagonist) was given by the peripheral intravenous route
before burn. These results were compared with those findings obtained
from a group of animals that received a burn only, and groups of anim
als given a peripheral intravenous injection of methysergide (a seroto
ninergic receptor antagonist) or ritanserin (a serotoninergic, recepto
r blocking agent) before burn. Experiments were conducted for two post
burn hours. Measurements and Main Results: Burn injury caused a marked
and persistent increase in regional (e.g, femoral artery) blood flow,
an effect that was significantly blunted by preburn administration of
the serotoninergic(2) receptor antagonist, methysergide. Preburn admi
nistration of BMY 7378 increased baseline femoral blood flow by 13%, r
eflecting its known serotonin agonist properties. However, when compar
ed with the mean postscald increases in femoral blood flow over baseli
ne seen in scald only dogs and in animals given the serotoninergic, re
ceptor blocking agent, ritanserin (before scald), the BMY 7378-treated
group demonstrated a significant (p < .001 by analysis of variance) 2
-hr-postscald blunting of this femoral vasodilator response. Conclusio
n: These data suggest that serotoninergic(1A)-like receptors play an i
ntegral, albeit not an exclusive, role in blood now regulation to the
site of burn injury.